The significant reduction of the clinical score in Asic2−/− mice in a limited time window, and, more importantly, the increased expression of ASIC2 in human brain MS samples, despite some limitations, suggests a possible role of ASIC2 in the pathophysiology of MS even if additional studies are required to firmly establish it. Here, ASIC2 is linked to myeloid sarcoma.